Rhinogenic Headache Improvement After Nasal Operation

Not Applicable

Terminated

• Conditions: Headache
• Interventions: Procedure: Septoplasty; Procedure: Septoplasty and endoscopic contact point correction

• Registration Number: NCT00580307
• Lead Sponsor: University of Missouri-Columbia

Brief Summary

Objective: To determine the efficacy of surgical correction of intranasal mucosal contact points in improving quality of life and decreasing medication use in patients with rhinogenic headaches.

Detailed Description

Significance: Chronic, debilitating headaches that resist maximal medical treatment by various headache specialists are sometimes linked to structural anomalies within the nose that exert pressure on apposing mucosal surfaces. A number of otolaryngologists have reported success in alleviating rhinogenic headaches with contact point correction surgery. This practice is supported by anecdotal reports along with retrospective and observational studies; however, a prospective study with an appropriate surgical control group has not been conducted. Because the specific effect of contact point correction has not yet been differentiated from the placebo effect of surgery itself, many headache specialists are reluctant to recommend surgical evaluation for their patients. To demonstrate the efficacy of contact point correction surgery to both the headache and otolaryngology communities - and thus, to make this treatment option more widely available to rhinogenic headache sufferers - a randomized controlled trial is needed.

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2007-12-12
• Study First Submitted QC: 2007-12-18
• Study First Posted: 2007-12-24
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-29
• Last Update Posted: 2016-09-30

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

• Chronic (> 2 months) pain or pressure over nasal bridge, glabella, or forehead
• Unilateral or bilateral nasal septal deviation that is chronically symptomatic (e.g. nasal airway obstruction)
• Failure of standard medical therapy for headache
• Symptomatic contact points as demonstrated by physical examination, sinus CT and nasal endoscopy
• Relief of headache after application of topical anesthetic to contact points
• Contact points that remain after mucosal decongestion
• Absence of any other obvious cause of headaches after a thorough evaluation by a neurologist, ophthalmologist, dentist, internist, or other related specialist

Exclusion Criteria

• Previous sinonasal surgery

• Active acute sinonasal disease:

  1. Seasonal allergic exacerbations with mucosal swelling
  2. Acute infectious rhino-sinusitis

• Chronic sinonasal problems:

  1. Severe nasal polyps mimicking contact points
  2. Mucoceles protruding from sinuses into nasal cavity
  3. Nasal and sinus tumors

• General medical condition that precludes elective surgery (including pregnancy)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Septoplasty	Septoplasty	Septoplasty only
Septoplasty and correction	Septoplasty and endoscopic contact point correction	Septoplasty and endoscopic contact point correction

Primary Outcome Measures

Name	Time	Method
Between-group difference in patient-rated headache improvement at 10 days, 6 weeks, 6 months and 12 months post-intervention, as measured by a validated questionnaire, the Headache Impact Test - 6 (HIT-6™).	12 months

Secondary Outcome Measures

Name	Time	Method
Between-group differences in subject responses to a non-validated questionnaire so as to permit comparison with previous studies. Additionally, headache medication use will be examined as a secondary end-point.	12 months

Trial Locations

Locations (1)

University of Missouri; 🇺🇸 Columbia, Missouri, United States